147 related articles for article (PubMed ID: 28337312)
1. pri-miR-34b/c rs4938723 polymorphism is associated with hepatocellular carcinoma risk: a case-control study in a Chinese population.
Liu CJ; Ma XW; Zhang XJ; Shen SQ
Int J Mol Epidemiol Genet; 2017; 8(1):1-7. PubMed ID: 28337312
[TBL] [Abstract][Full Text] [Related]
2. Association between polymorphisms in the promoter region of pri-miR-34b/c and risk of hepatocellular carcinoma.
Chen LL; Shen Y; Zhang JB; Wang S; Jiang T; Zheng MQ; Zheng ZJ; Chen CX
Genet Mol Res; 2016 Oct; 15(4):. PubMed ID: 27808368
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of the pri-miR-34b/c rs4938723 polymorphism and its association with breast cancer risk.
Sanaei S; Hashemi M; Rezaei M; Hashemi SM; Bahari G; Ghavami S
Biomed Rep; 2016 Jul; 5(1):125-129. PubMed ID: 27347415
[TBL] [Abstract][Full Text] [Related]
4. Combined analysis of pri-miR-34b/c rs4938723 and TP53 Arg72Pro with cervical cancer risk.
Yuan F; Sun R; Chen P; Liang Y; Ni S; Quan Y; Huang J; Zhang L; Gao L
Tumour Biol; 2016 May; 37(5):6267-73. PubMed ID: 26619844
[TBL] [Abstract][Full Text] [Related]
5. Associations of pri-miR-34b/c and pre-miR-196a2 polymorphisms and their multiplicative interactions with hepatitis B virus mutations with hepatocellular carcinoma risk.
Han Y; Pu R; Han X; Zhao J; Zhang Y; Zhang Q; Yin J; Xie J; Shen Q; Deng Y; Ding Y; Li W; Li J; Zhang H; Cao G
PLoS One; 2013; 8(3):e58564. PubMed ID: 23516510
[TBL] [Abstract][Full Text] [Related]
6. A potentially functional polymorphism in the promoter region of miR-34b/c is associated with an increased risk for primary hepatocellular carcinoma.
Xu Y; Liu L; Liu J; Zhang Y; Zhu J; Chen J; Liu S; Liu Z; Shi H; Shen H; Hu Z
Int J Cancer; 2011 Jan; 128(2):412-7. PubMed ID: 20309940
[TBL] [Abstract][Full Text] [Related]
7. Pri-miR-34b/c rs4938723 Polymorphism Contributes to Coronary Artery Disease Susceptibility.
Cen J; Xiong Q; Yang X; Guo J; Xiong XD; Zhang A
Arch Med Res; 2019 May; 50(4):170-174. PubMed ID: 31499476
[TBL] [Abstract][Full Text] [Related]
8. Pri-miR-34b/c rs4938723 polymorphism increased the risk of prostate cancer.
Hashemi M; Danesh H; Bizhani F; Narouie B; Sotoudeh M; Nouralizadeh A; Sharifiaghdas F; Bahari G; Taheri M
Cancer Biomark; 2017; 18(2):155-159. PubMed ID: 27983526
[TBL] [Abstract][Full Text] [Related]
9. The genetic association between pri-miR-34b/c polymorphism (rs4938723 T > C) and susceptibility to cancers: evidence from published studies.
Li X; Wang L; Yu J; Xu J; Du J
Tumour Biol; 2014 Dec; 35(12):12525-34. PubMed ID: 25190019
[TBL] [Abstract][Full Text] [Related]
10. Pri-miR-34b/c rs4938723 polymorphism is associated with a decreased risk of gastric cancer.
Pan XM; Sun RF; Li ZH; Guo XM; Qin HJ; Gao LB
Genet Test Mol Biomarkers; 2015 Apr; 19(4):198-202. PubMed ID: 25658980
[TBL] [Abstract][Full Text] [Related]
11. Pri-Mir-34b/C and Tp-53 Polymorphisms are Associated With The Susceptibility of Papillary Thyroid Carcinoma: A Case-Control Study.
Chen P; Sun R; Pu Y; Bai P; Yuan F; Liang Y; Zhou B; Wang Y; Sun Y; Zhu J; Zhang L; Gao L
Medicine (Baltimore); 2015 Sep; 94(38):e1536. PubMed ID: 26402809
[TBL] [Abstract][Full Text] [Related]
12. Pri-miR-34b/c rs4938723 TC heterozygote is associated with increased cancer risks: evidence from published data.
Yi DH; Wang BG; Zhong XP; Liu H; Liu YF
Tumour Biol; 2014 Dec; 35(12):11967-75. PubMed ID: 25201061
[TBL] [Abstract][Full Text] [Related]
13. Interactions of miR-34b/c and TP-53 polymorphisms on the risk of nasopharyngeal carcinoma.
Li L; Wu J; Sima X; Bai P; Deng W; Deng X; Zhang L; Gao L
Tumour Biol; 2013 Jun; 34(3):1919-23. PubMed ID: 23504554
[TBL] [Abstract][Full Text] [Related]
14. Association between hsa-miR-34b/c rs4938723 T > C promoter polymorphism and cancer risk: a meta-analysis based on 6,036 cases and 6,204 controls.
Tao T; Chen S; Xu B; Liu C; Wang Y; Huang Y; Chen M
Chin J Cancer Res; 2014 Jun; 26(3):315-22. PubMed ID: 25035659
[TBL] [Abstract][Full Text] [Related]
15. Promoter polymorphisms of pri-miR-34b/c are associated with hepatocellular carcinoma.
Son MS; Jang MJ; Jeon YJ; Kim WH; Kwon CI; Ko KH; Park PW; Hong SP; Rim KS; Kwon SW; Hwang SG; Kim NK
Gene; 2013 Jul; 524(2):156-60. PubMed ID: 23632240
[TBL] [Abstract][Full Text] [Related]
16. A potentially functional polymorphism in the promoter region of miR-34b/c is associated with renal cell cancer risk in a Chinese population.
Zhang S; Qian J; Cao Q; Li P; Wang M; Wang J; Ju X; Meng X; Lu Q; Shao P; Zhang Z; Qin C; Yin C
Mutagenesis; 2014 Mar; 29(2):149-54. PubMed ID: 24503183
[TBL] [Abstract][Full Text] [Related]
17. Pri-miR-34b/c rs4938723 Polymorphism is Associated with Decreased Risk and Better Prognosis for Colorectal Cancer Patients.
Kassim SA; Yang X; Abbas M; Wu S; Faran Ashraf Baig MM; Meng QT; Zhang C; Li X; Chen R
Arch Med Res; 2019 Feb; 50(2):55-62. PubMed ID: 31349954
[TBL] [Abstract][Full Text] [Related]
18. Pri-miR-34b/c rs4938723 polymorphism is associated with the risk of childhood acute lymphoblastic leukemia.
Hashemi M; Bahari G; Naderi M; Sadeghi-Bojd S; Taheri M
Cancer Genet; 2016 Nov; 209(11):493-496. PubMed ID: 27886674
[TBL] [Abstract][Full Text] [Related]
19. Genetic polymorphisms of miRNA let7a-2 and pri-mir-34b/c are associated with an increased risk of papillary thyroid carcinoma and clinical/pathological features.
Heidari Z; Mohammadpour-Gharehbagh A; Eskandari M; Harati-Sadegh M; Salimi S
J Cell Biochem; 2019 May; 120(5):8640-8647. PubMed ID: 30552691
[TBL] [Abstract][Full Text] [Related]
20. Association Between Genetic Variant in the Promoter of Pri-miR-34b/c and Risk of Glioma.
Li J; Liu X; Qiao Y; Qi R; Liu S; Guo J; Gui Y; Li J; Yu H
Front Oncol; 2018; 8():413. PubMed ID: 30319976
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
